Medsafe renews COVID-19 vaccine provisional approval
Quiet and under the radar News article 28 October 2021 Today Medsafe announces its decision to renew the provisional approval for the Pfizer COVID-19 vaccine, says Medsafe Group Manager Chris James. The renewal of provisional approval is for a period of two years, until 3 November 2023. “Pfizer has met all obligations required to date by the conditions of the provisional approval granted in February this year. This included providing additional data about the clinical trials and vaccine monitoring. “By…
